3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Delayed surgery decreases bladder cancer survival

CancerApr 13, 06

For patients newly diagnosed with bladder cancer, delays of more than 3 months after the initial diagnosis to surgery results in decreased survival, a study shows.

“There currently are no standardized guidelines for the appropriate timing of cystectomy” (surgical removal of the bladder), Dr. Cheryl T. Lee from University of Michigan, Ann Arbor, Michigan told Reuters Health. “However, there is growing evidence that cystectomy should be performed within 3 months of a diagnosis” of muscle-invasive disease.

The current study, she said, supports that “patients must undergo cystectomy within 3 months of diagnosis or their survival may be compromised.”

Lee and colleagues evaluated the timing from the diagnosis of bladder cancer to cystectomy in 214 consecutive patients to assess its impact on survival.

By investigating each delay duration, the authors were able to identify a delay of 93 days as the first cutoff point that resulted in a significantly decreased overall survival and so-called disease-specific survival.

Three-year disease-specific survival was 62 percent for patients who underwent cystectomy within 93 days of diagnosis and 49 percent for those who underwent surgery later, the researchers note.

Three-year overall survival was 51 percent and 38 percent, respectively, for patients operated within and beyond 93 days of diagnosis.

Patients who had a cystectomy delay of more than 93 days faced about twice the risk of patients who had an earlier cystectomy of dying from any cause or from bladder cancer, according to a multivariate analysis.

Nearly half the scheduling delays in patients who underwent cystectomy after 93 days were related to clinical or research appointments, the investigators say. Patient co-morbidities accounted for 15 percent of the delays, and difficulty with decision-making contributed to 12 percent of the delays.

“Rigorous coordination of preoperative counseling, medical clearance, and patient education is required to permit an efficient decision-making process and timely delivery of surgery,” Lee said.

SOURCE: The Journal of Urology April 2006.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site